Patient Guide: A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 53 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05901649
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Hormone-sensitive Prostate Cancer
Phase: Not Specified

Find a Study Location Near You

This study is available at 53 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Vienna,
  • Wels,
  • Avignon,
  • • And 50 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily